Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.
| Revenue (TTM) | $30.85M |
| Gross Profit (TTM) | $5.65M |
| EBITDA | $-91.51M |
| Operating Margin | -667.00% |
| Return on Equity | -90.30% |
| Return on Assets | -17.00% |
| Revenue/Share (TTM) | $0.28 |
| Book Value | $2.03 |
| Price-to-Book | 2.26 |
| Price-to-Sales (TTM) | 20.87 |
| EV/Revenue | 19.85 |
| EV/EBITDA | -12.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 327.60% |
| Shares Outstanding | $153.31M |
| Float | $132.72M |
| % Insiders | 10.77% |
| % Institutions | 48.08% |
Volatility is currently contracting
ASP Isotopes NASDAQ: ASPI expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference presentation.
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among the first new liquid helium supply to enter the market at a time of acute global shortage The Company remains on track to deliver liquid helium to customers during September and ramp production to nameplate capacity during 2H Following the successful start-up of Phase 1, the Company expects to advance to Phase 2 during 2H 2026. The Company is currently exploring ways to accelerate the revenues and cash flows from Phase 2 DALLAS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Tetra4 Proprietary Limited, a subsidiary of Renergen Limited (“Renergen”) and the developer of the Virginia Gas Project, has entered the commissioning phase of the Company's liquid helium plant.
DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, is evaluating metal conversion opportunities in Namibia. As part of this evaluation, a public environmental and social impact assessment and consultation process has commenced for a proposed pilot-scale hydrofluorination and fluorination facility in the Walvis Bay area of Namibia.
ASP Isotopes NASDAQ: ASPI outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity's 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for completion in the third quarter of 2026
DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will host investor meetings at Citi's 2026 Natural Resources Conference on Thursday, August 13, 2026, in Las Vegas, Nevada.
Washington D.C., August 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aeternum Health (OTC: AETN) (“Company”), today announced a change in strategy, new management and provides investors with an update on corporate progress.
DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Viktor Petkov, Chief Commercial Officer, will deliver a company presentation on Wednesday, August 12, 2026, at 8:00 a.m. ET. A live audio webcast of the presentation will be available in the Investors section of the Company's website at www.aspisotopes.com.
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST).
ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASPI and any ticker you trade — then tracks every position and per-strategy win rate.
